These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37738154)

  • 1. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
    Liu J; Zhao J; Qiao X
    Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits proliferation of oral squamous cell carcinoma cells by suppressing proteolysis of nerve growth factor receptor.
    Wei J; Huang J; Kuang Y; Li Y; Zhong D; Song J
    Arch Oral Biol; 2021 Jan; 121():104971. PubMed ID: 33220581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits oral squamous cell carcinoma progression through regulating RNA alternative splicing.
    Ji M; Lv Y; Chen C; Xing D; Zhou C; Zhao J; Qi Y; Zhang J; Wang Y; Ma X; Xu W; Zhang W; Li X
    Life Sci; 2023 Feb; 315():121274. PubMed ID: 36509195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma.
    He Y; Tai S; Deng M; Fan Z; Ping F; He L; Zhang C; Huang Y; Cheng B; Xia J
    Cancer Med; 2019 Jul; 8(7):3479-3490. PubMed ID: 31025540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acid-induced M2-like macrophages facilitate tumor cell migration and invasion via the GPNMB/CD44 axis in oral squamous cell carcinoma.
    Lin Y; Qi Y; Jiang M; Huang W; Li B
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110972. PubMed ID: 37806107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The inhibitory effect of metformin on oral squamous cell carcinoma].
    Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma.
    Wang WM; Yang SS; Shao SH; Nie HQ; Zhang J; Su T
    Front Endocrinol (Lausanne); 2022; 13():828608. PubMed ID: 35222283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
    Lin YC; Chen BS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway.
    Zhang Z; Liang X; Fan Y; Gao Z; Bindoff LA; Costea DE; Li L
    Cell Cycle; 2019 May; 18(9):949-962. PubMed ID: 31014173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
    Duan Y; Huang X; Qiao B; Ma R; Li J
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
    Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
    J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.
    Benhamou Y; Picco V; Raybaud H; Sudaka A; Chamorey E; Brolih S; Monteverde M; Merlano M; Lo Nigro C; Ambrosetti D; Pagès G
    Oncotarget; 2016 Jul; 7(28):44236-44251. PubMed ID: 27329590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
    Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
    Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.